Table 2

- Distribution of survival status in relation to the demographics, chronic medical illnesses, and COVID-19 symptoms in the study population (N=248).

Parameter	Survivals		Non-survivors		Long rank test	P-value
Parameter	n	%	n	%	Long rank test	P-value
Age
<50 years	111	89.5	13	10.5	5.0	0.03^*
50+ years	91	74.0	32	26.0	5.0	0.03^*
Gender
Female	48	80.0	12	20.0	0.24	0.62
Male	155	82.5	33	17.6	0.24	0.62
*Chronic medical illnesses*
Chronic cardiac disease
No	190	84.8	34	15.2	10.05	0.002^*
Yes	13	54.2	11	45.8	10.05	0.002^*
Hypertension
No	149	85.6	25	14.4	3.33	0.06
Yes	54	73.0	20	27.0	3.33	0.06
Diabetes mellitus
No	141	87.0	21	13.0	4.87	0.08
Type I	8	47.1	9	52.9
Type II	54	78.3	15	21.7
Asthma
No	200	82.6	42	17.4	4.75	0.03^*
Yes	3	50.0	3	50.0	4.75	0.03^*
Renal disease
No	199	83.3	40	16.7	1.18	0.27
Yes	4	44.4	5	55.6	1.18	0.27
Hepatic disease
No	202	82.1	44	17.9	0.08	0.78
Yes	1	50.0	1	50.0	0.08	0.78
Neurological disorder
No	199	81.9	44	18.1	0.24	0.62
Yes	4	80.0	1	20.0	0.24	0.62
Malignancy
No	202	81.8	45	18.2	0.27	0.60
Yes	1	100.0	0	0.0	0.27	0.60
*Presenting COVID-19 symptoms*
Fever
No	75	93.8	5	6.3	4.49	0.03^*
Yes	128	76.2	40	23.8	4.49	0.03^*
Cough
No	94	81.7	21	18.3	0.24	0.62
Yes	41	78.9	11	21.2	0.24	0.62
Sore throat
No	176	80.7	42	19.3	0.01	0.94
Yes	27	90.0	3	10.0	0.01	0.94
Runny nose
No	191	81.3	44	18.7	0.57	0.45
Yes	12	92.3	1	7.7	0.57	0.45
Wheeze
No	201	81.7	45	18.3	0.81	0.36
Yes	2	100.0	0	0.0	0.81	0.36
Shortness of breath
No	102	90.3	11	9.7	7.35	0.007^*
Yes	101	74.8	34	25.2	7.35	0.007^*
Fatigue
No	195	81.6	44	18.4	0.03	0.85
Yes	8	88.9	1	11.1	0.03	0.85
Muscle ache
No	192	81.7	43	18.3	2.95	0.08
Yes	11	84.6	2	15.4	2.95	0.08